Athletes and High Performers : Intense training creates oxidative stress that depletes glutathione
Erin Hartmann, J.D., is manager of regulatory affairs in Eliquent Life Sciences Quality and Compliance Practice
NICE recommends GLP-1 therapy for type 2 diabetes (NG28) when: HbA1c remains elevated despite dual therapy with metformin and another oral agent The patient has a BMI of 35 kg/m or higher (or lower thresholds for certain ethnic groups) Significant weight loss would benefit other obesity-related comorbidities Insulin therapy poses specific risks or is declined by the patient For weight management, NICE has approved specific GLP-1 receptor agonists through Technology Appraisals
The regulation of OXPHOS by extramitochondrial calcium
The evidence suggests that Inositol, vitamin D, omega-3 fatty acids, coenzyme Q10, curcumin, and oleoyl ethanolamide benefit insulin sensitivity, glucose metabolism, and inflammatory markers